Since large trials have been set up to assess whether tamoxifen decreases the risk of breast cancer in healthy women, it has become important to investigate the drug's potential adverse effects, including occurrence of endometrial cancer. We undertook a case-cont
To evaluate the effect of tamoxifen on cervicovaginal epithelium and determine the value of cervicov...
Introduction: Tamoxifen is an effective treatment for breast cancer but an undesirable side-effect i...
WOS: 000078321800017PubMed ID: 10215447Objective: To investigate the effects of tamoxifen on the end...
Background Tamoxifen increases the risk of endometrial cancer. However, few studies have produced re...
Background: Tamoxifen treatment of breast cancer is as-sociated with an increased risk of endometria...
Tamoxifen is a non-steroid estrogenic antagonist, used in post-surgical therapy of breast cancer. It...
Tamoxifen is the most used adjuvant drug in breast cancer treatment. Its main action is as an anti-o...
therapy increases endometrial cancer risk among tamoxifen-treated breast cancer survivors in Taiwan...
Tamoxifen, a selective estrogen receptor modulator (SERM), is used as an estrogen antagonist for al...
Tamoxifen, a selective estrogen receptor modulator (SERM), is used as an estrogen antagonist for all...
OBJECTIVE: To determine the effect of tamoxifen on the endometrium in postmenopausal women with brea...
The proliferative effect of adjuvant tamoxifen on the endometrium can potentially result in endometr...
The aim of this retrospective study was to detect endometrial lesions in tamoxifen breast cancer use...
The objective of the study was to determine the incidence and type of endometrial abnormalities in l...
Endocrine therapy is the mainstay treatment for hormone receptor-positive ductal carcinoma in situ. ...
To evaluate the effect of tamoxifen on cervicovaginal epithelium and determine the value of cervicov...
Introduction: Tamoxifen is an effective treatment for breast cancer but an undesirable side-effect i...
WOS: 000078321800017PubMed ID: 10215447Objective: To investigate the effects of tamoxifen on the end...
Background Tamoxifen increases the risk of endometrial cancer. However, few studies have produced re...
Background: Tamoxifen treatment of breast cancer is as-sociated with an increased risk of endometria...
Tamoxifen is a non-steroid estrogenic antagonist, used in post-surgical therapy of breast cancer. It...
Tamoxifen is the most used adjuvant drug in breast cancer treatment. Its main action is as an anti-o...
therapy increases endometrial cancer risk among tamoxifen-treated breast cancer survivors in Taiwan...
Tamoxifen, a selective estrogen receptor modulator (SERM), is used as an estrogen antagonist for al...
Tamoxifen, a selective estrogen receptor modulator (SERM), is used as an estrogen antagonist for all...
OBJECTIVE: To determine the effect of tamoxifen on the endometrium in postmenopausal women with brea...
The proliferative effect of adjuvant tamoxifen on the endometrium can potentially result in endometr...
The aim of this retrospective study was to detect endometrial lesions in tamoxifen breast cancer use...
The objective of the study was to determine the incidence and type of endometrial abnormalities in l...
Endocrine therapy is the mainstay treatment for hormone receptor-positive ductal carcinoma in situ. ...
To evaluate the effect of tamoxifen on cervicovaginal epithelium and determine the value of cervicov...
Introduction: Tamoxifen is an effective treatment for breast cancer but an undesirable side-effect i...
WOS: 000078321800017PubMed ID: 10215447Objective: To investigate the effects of tamoxifen on the end...